Publications by authors named "M Bouvet"

Claim this Profile
M
Methionine Restriction, Not Cysteine Restriction, Is a Cancer-specific Vulnerability.
Yuta Miyashi, Kohei Mizuta, Yohei Asano, Byung Mo Kang, Jin Soo Kim, Michael Bouvet

Anticancer Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Recombinant Methioninase Dose and Timing on the Selective and Precise Elimination of Cancer Cells from Co-Cultured Normal Cells and on Methionine-dependent Rescue of Cancer Cells.
Jinsoo Kim, Qinghong Han, Shukuan Li, Byung Mo Kang, Kohei Mizuta, Michael Bouvet

Anticancer Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal Cells.
Byung Mo Kang, Qinghong Han, Shukuan Li, Jin Soo Kim, Kohei Mizuta, Michael Bouvet

Cancer Diagn Progn· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on the diagnostic and prognostic value of mucin 4 in gastric cancers.
Abhijit Aithal, Blackberrie Eddins, Michael Bouvet, Valerie P O'Brien, Maneesh Jain

Expert Rev Mol Diagn· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression.
Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung Mo Kang, Michael Bouvet

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis